Drug research

TP-03 Vehicle

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDNCT05454956	TARS	Phase 2	Completed	2023-05-18Actual
Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04784091	TARS	Phase 3	Completed	2022-05-09Actual
Safety and Efficacy of TP-03 for the Treatment of Demodex BlepharitisNCT04475432	TARS	Phase 2, Phase 3	Completed	2021-05-04Actual

TARSCompletedPrimary completion: 2023-05-18 · Actual

Trial details

TARSCompletedPrimary completion: 2022-05-09 · Actual

Trial details

TARSCompletedPrimary completion: 2021-05-04 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.